Kabiven Perifer

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin, the active ingredient in Kabiven Perifer, is a parenteral nutrition solution presented as a solution for injection for intravenous use. It provides essential amino acids for patients who cannot receive enteral feeding, supporting protein synthesis and metabolic needs in critically ill or postoperative settings.

GNH USA supplies Kabiven Perifer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and clinics worldwide through a regulated distribution network.

Kabiven Perifer is employed in parenteral nutrition to meet protein and caloric requirements when oral or enteral intake is not possible. - Inability to receive enteral feeding: provides essential amino acids to sustain protein synthesis and metabolic balance. - Critical illness: supports caloric and nitrogen needs during intensive care or severe catabolism. - Post‑operative recovery: aids wound healing and muscle preservation when oral intake is delayed.

Kabiven Perifer may be associated with infusion‑related and systemic adverse reactions.

Common Side Effects: - Infusion site erythema - Mild fever - Nausea - Electrolyte disturbances (e.g., mild hypernatremia)

Serious or Rare Side Effects: - Anaphylactic reaction - Severe hyperglycemia - Catheter‑related bloodstream infection - Renal or hepatic dysfunction

When using Kabiven Perifer, clinicians should observe several safety precautions to minimize complications. - Assess renal and hepatic function before initiation: baseline labs guide dosing and monitoring. - Monitor blood glucose and electrolyte levels regularly: amino acid metabolism can affect glucose and sodium balance. - Adjust infusion rate based on patient tolerance: rapid administration may cause hypotension or discomfort. - Avoid mixing with incompatible solutions: incompatibility can cause precipitation or loss of efficacy. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kabiven Perifer can interact with other medications or solutions administered intravenously.

Major Interactions (Avoid): - Concurrent high‑dose potassium solutions: may cause dangerous hyperkalemia. - Co‑administration with other amino‑acid formulations: risk of incompatibility and precipitation. - Use with nephrotoxic drugs: increased renal load may exacerbate kidney injury.

Moderate Interactions (Monitor Closely): - Concurrent insulin therapy: amino acids can raise blood glucose, requiring insulin dose adjustment. - Use with diuretics: monitor electrolytes closely for shifts in sodium and potassium. - Simultaneous administration of other parenteral nutrition components: watch osmolarity and fluid balance.